Chemokine receptor antagonist 

Chemokine receptor antagonists inhibit the entry of human immunodeficiency virus (HIV) into the host cell. Two chemokine receptors, CXCR4 and CCR5, are necessary for the virus to enter the cell, so by inhibiting these chemokine receptors the disease can be slowed.

What are Chemokine receptor antagonist? Chemokine receptor antagonists inhibit the entry of human immunodeficiency virus (HIV) into the host cell. Two chemokine receptors, CXCR4 and CCR5, are necessary for the virus to enter the cell, so by inhibiting these chemokine receptors the disease can be slowed.

Integrin antagonists work by blocking the binding sites on integrins, thereby preventing these receptors from interacting with their extracellular matrix (ECM) ligands or other cell surface molecules. This blockade can inhibit the transmission of signals that are essential for various cellular functions.